Please upgrade your browser.
for The Judy Nicholson Foundation, a charitable foundation established January 2009 after the wife of its founder, Judy Nicholson, passed away after a battle with RCC. The Foundation seeks to raise funds in partnership with researchers at the Mayo Clinic Florida in Jacksonville in an effort to find a method for early detection of kidney cancer and improved treatment. We also seek to increase awareness of this devastating disease through events and promotions and through a strong support group in the Jacksonville area. The Judy Nicholson Foundation is a 501(c)3 charity, has no paid employees and 95% of donations are applied to research grants.
Global Markets Direct's, 'Renal Cell Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.
Everyone goes through a time of panic and fear. Get past that and be optimistic!
Illinois has proclaimed March, 2013, as Kidney Cancer Awareness Month.
Save the date for our biggest survivor-patient meeting of the year! Join us on Saturday, April 4 for the 2013 Kidney Cancer Association Patient and Survivor Conference in Houston, TX.
March, 2013, is Kidney Cancer Awareness Month--wear ORANGE every day to create awareness of the need for a cure.
Vasohibin-1 (VASH1) is an endothelium-produced angiogenesis inhibitor. Renal cell carcinoma is highly vascularised, but the significance of endogenous VASH1 in renal cell carcinoma has not been defined.
Once again, NICE regulators toss kidney cancer sufferers into medicine's "dust bin."
Stanford University scientists have discovered a single drug that has killed or shrunk every kind of cancer tumor it has been used against — a new anti-cancer weapon that some have described as a kind of medical Holy Grail.
Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was turned down for use on the state health service.
|Powered by NeonCRM|